Centric Medical, a division of Life Spine, announced FDA 510(k) clearance of the TARSA-LINK™ Bunion Correction System, indicated for internal bone fixation for bunionectomies, opening base wedge osteotomies, bone fractures, fusions or trauma. TARSA-LINK is reported to be the first-to-market standalone opening base wedge to feature built-in fixation. Launch is slated for 4Q16.
Centric Medical, a division of Life Spine, announced FDA 510(k) clearance of the TARSA-LINK™ Bunion Correction System, indicated for internal bone fixation for bunionectomies, opening base wedge osteotomies, bone fractures, fusions or trauma. TARSA-LINK is reported to be the first-to-market standalone opening base wedge to feature built-in...
Centric Medical, a division of Life Spine, announced FDA 510(k) clearance of the TARSA-LINK™ Bunion Correction System, indicated for internal bone fixation for bunionectomies, opening base wedge osteotomies, bone fractures, fusions or trauma. TARSA-LINK is reported to be the first-to-market standalone opening base wedge to feature built-in fixation. Launch is slated for 4Q16.
Copy to clipboard 
